Skip to main content

Advertisement

SpringerLink
Log in

Sedative Load and Mortality among Residents of Long-Term Care Facilities

A Prospective Cohort Study

  • Original Research Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Background: Older people are often prescribed multiple drugs with sedative properties. Most research has focused on specific classes of sedative and psychotropic drugs. The cumulative effect of taking multiple drugs with sedative properties has been termed ‘sedative load’. Few previous studies have investigated the sedative load among residents of long-term care facilities. No previous studies have assessed the possible association between sedative load and mortality.

Objective: The objective of this study was to describe the sedative load among residents of long-term care facilities, and to investigate a possible association between sedative load and mortality.

Methods: This was a prospective cohort study. The study population comprised all 1444 residents of 53 long-term care wards in seven hospitals in Helsinki during September 2003. Of the eligible residents, 1087 residents or their proxies provided written informed consent to participate. Medical, medication and follow-up mortality data were available for 1004 residents. The main outcome measures were sedative load and all-cause mortality.

Results: The mean age of the residents was 81.3 (SD 10.9) years, and the mean number of regularly used drugs per resident was 7.1 (SD 3.4). Fifteen percent of residents were categorized as non-users of sedative drugs, 32% as users of some drugs with sedative properties and 53% as residents with a high sedative load. There was a bivariate association between having a higher sedative load and younger age (p < 0.001), male sex (p = 0.006), not being widowed (p = 0.001), diagnosis of depression (p < 0.001), diagnosis of psychiatric illness other than depression (p < 0.001), not being diagnosed with dementia (p = 0.009) and a shorter duration of institutional care (p = 0.02). Unadjusted analysis revealed that having a higher sedative load was associated with increased survival (p = 0.04, log rank test). However, in the adjusted Cox proportional hazard model, only poor nutritional status (hazard ratio [HR] 1.55; 95% CI 1.32, 1.82), male sex (HR 1.37; 95% CI 1.12, 1.69), increasing age (HR 1.04; 95% CI 1.03, 1.05) and co-morbidity (HR 1.07; 95% CI 1.02, 1.13) were significantly associated with risk of death.

Conclusions: There is a very high rate of sedative and psychotropic drug use among residents of long-term care facilities in Helsinki. However, having a high sedative load was not associated with an increased risk of death. Further research is needed to investigate the possible association between sedative load and mortality using alternative models and methods, and in different resident populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I
Table II
Table III
Fig. 2
Table IV

Similar content being viewed by others

References

  1. Nygaard HA, Naik M, Ruths S, et al. Nursing-home residents and their drug use: a comparison between mentally intact and mentally impaired residents. The Bergen district nursing home (BEDNURS) study. Eur J Clin Pharmacol 2003; 59: 463–9

    Article  PubMed  Google Scholar 

  2. Wancata J, Benda N, Meise U, et al. Psychotropic drug intake in residents newly admitted to nursing homes. Psychopharmacology (Berl) 1997; 134: 115–20

    Article  CAS  Google Scholar 

  3. Alanen H-M, Finne-Soveri H, Noro A, et al. Use of antipsychotic medications among elderly residents in long term institutional care: a three year follow-up. Int J Geriatr Psychiatry 2006; 21: 288–95

    Article  PubMed  Google Scholar 

  4. Snowdon J. A follow-up survey of psychotropic drug use in Sydney nursing homes. Med J Aust 1999; 170: 299–301

    PubMed  CAS  Google Scholar 

  5. Hosia-Randell H, Pitkälä K. Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Aging 2005; 22: 793–800

    Article  PubMed  Google Scholar 

  6. Holmquist IB, Svensson B, Hoglund P. Psychotropic drugs in nursing and old age homes: relationships between needs of care and mental health status. Eur J Clin Pharmacol 2003; 59: 669–76

    Article  PubMed  Google Scholar 

  7. Lasser RA, Sunderland T. Newer psychotropic medication use in nursing home residents. J Am Geriatr Soc 1998; 46: 202–7

    PubMed  CAS  Google Scholar 

  8. van Dijk KN, de Vries CS, van den Berg PB, et al. Drug utilisation in Dutch nursing homes. Eur J Clin Pharmacol 2000; 55: 765–71

    Article  PubMed  Google Scholar 

  9. Sorensen L, Foldspang A, Gulmann NC, et al. Determinants for the use of psychotropics among nursing home residents. Int J Geriatr Psychiatry 2001; 16: 147–54

    Article  PubMed  CAS  Google Scholar 

  10. Ruths S, Straand J, Nygaard HA. Psychotropic drug use in nursing homes: diagnostic indications and variations between institutions. Eur J Clin Pharmacol 2001; 57: 523–8

    Article  PubMed  CAS  Google Scholar 

  11. Cumming RG, Le Couteur DG. Benzodiazepines and the risk of hip fractures in older people: a review of the evidence. CNS Drugs 2003; 17: 825–37

    Article  PubMed  CAS  Google Scholar 

  12. Hartikainen S, Lönnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci 2007; 62: 1172–81

    Article  PubMed  Google Scholar 

  13. Hanlon JT, Horner RD, Schmader KE, et al. Benzodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Ther 1998; 64: 684–92

    Article  PubMed  CAS  Google Scholar 

  14. Ried LD, Johnson RE, Gettman DA. Benzodiazepine exposure and functional status in older people. J Am Geriatr Soc 1998; 46: 71–6

    PubMed  CAS  Google Scholar 

  15. Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional versus atypical antipsychotic medications. N Engl J Med 2005; 353: 2335–41

    Article  PubMed  CAS  Google Scholar 

  16. Gill SS, Bronskill SE, Normand SL, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007; 146: 775–86

    PubMed  Google Scholar 

  17. Raivio MM, Laurila JV, Strandberg TE, et al. Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study. Am J Geriatr Psychiatry 2007; 15: 416–24

    Article  PubMed  Google Scholar 

  18. Hollis J, Grayson D, Forrester L, et al. Antipsychotic medication dispensing and risk of death in veterans and war widows 65 years and older. Am J Geriatr Psychiatry 2007; 15: 932–41

    Article  PubMed  Google Scholar 

  19. Schneeweiss S, Setoguchi S, Brookhart A, et al. Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. Can Med Assoc J 2007; 176: 627–32

    Article  Google Scholar 

  20. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005; 294: 1934–43

    Article  PubMed  CAS  Google Scholar 

  21. Suh GH, Shah A. Effect of antipsychotics on mortality in elderly patients with dementia: a 1-year prospective study in a nursing home. Int Psychogeriatr 2007; 17: 429–41

    Article  Google Scholar 

  22. Setoguchi S, Wang PS, Brookhart A, et al. Potential causes of higher mortality in elderly users of conventional and atypical antipsychotic medications. J Am Geriatr Soc 2008; 53: 1644–50

    Article  Google Scholar 

  23. Trifiro G, Verhamme KM, Ziere G, et al. All-cause mortality associated with atypical and typical antipsychotics in demented outpatients. Pharmacoepidemiol Drug Saf 2007; 16: 538–44

    Article  PubMed  CAS  Google Scholar 

  24. Nonino F, De Girolamo G, Gamberini L, et al. Modena Work Group for Antipsychotics in Dementia. Survival among elderly Italian patients with dementia treated with atypical antipsychotics: observational study. Neurol Sci 2006; 27: 375–80

    Article  PubMed  CAS  Google Scholar 

  25. Vinkers DJ, Gussekloo J, van der Mast RC, et al. Benzodiazepine use and risk of mortality in individuals aged 85 years or older. JAMA 2003; 290: 2942–3

    Article  PubMed  CAS  Google Scholar 

  26. Merlo J, Ostergren PO, Mansson NO, et al. Mortality in elderly men with low psychosocial coping resources using anxiolytic-hypnotic drugs. Scand J Public Health 2000; 28: 294–7

    PubMed  CAS  Google Scholar 

  27. Kripke DF, Klauber MR, Wingard DL, et al. Mortality hazard associated with prescription hypnotics. Biol Psychiatry 1998; 43: 687–93

    Article  PubMed  CAS  Google Scholar 

  28. Ryan J, Carriere I, Ritchie K, et al. Late-life depression and mortality: influence of gender and antidepressant use. Br J Psychiatry 2008; 192: 12–8

    Article  PubMed  Google Scholar 

  29. Hublin C, Partinen M, Koskenvuo M, et al. Sleep and mortality: a population-based 22-year follow-up study. Sleep 2007; 30: 1245–53

    PubMed  Google Scholar 

  30. Hartikainen S, Rahkonen T, Kautianen H, et al. The use of psychotropics and survival in demented elderly individuals. Int Clin Psychopharmacol 2005; 20: 227–31

    Article  PubMed  Google Scholar 

  31. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007; 5: 345–51

    Article  PubMed  Google Scholar 

  32. Linjakumpu T, Hartikainen S, Klaukka T, et al. A model to classify the sedative load of drugs. Int J Geriatr Psychiatry 2003; 18: 542–4

    Article  PubMed  CAS  Google Scholar 

  33. Sloane P, Ivey J, Roth M, et al. Accounting for the sedative and analgesic effects of medication changes during patient participation in clinical research studies: measurement development and application to a sample of institutionalized geriatric patients. Contemp Clin Trials 2008; 29: 140–8

    Article  PubMed  Google Scholar 

  34. Linjakumpu TA, Hartikainen SA, Klaukka TJ, et al. Sedative drug use in the home dwelling elderly. Ann Pharmacother 2004; 38: 2017–22

    Article  PubMed  Google Scholar 

  35. Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medication in older people. Arch Intern Med 2007; 167: 781–7

    Article  PubMed  Google Scholar 

  36. Suominen MH, Sandelin E, Soini H, et al. How well do nurses recognize malnutrition in elderly patients? Eur J Clin Nutr 2009; 63: 292–6

    Article  PubMed  CAS  Google Scholar 

  37. WHO Collaborating Centre for Drug Statistics Methodology. The anatomical therapeutic chemical classification system, 2008 [online]. Available from URL: http://www.whocc.no/atcddd/ [Accessed 2009 Jun 11]

  38. Hosia-Randell HM, Muurinen SM, Pitkälä KH. Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging 2008; 25: 683–92

    Article  PubMed  CAS  Google Scholar 

  39. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and evaluation. J Chronic Dis 1987; 40: 373–83

    Article  PubMed  CAS  Google Scholar 

  40. Buntinx F, Niclaes L, Suetens C, et al. Evaluation of Charlson’s comorbidity index in elderly living in nursing homes. J Clin Epidemiol 2002; 55: 1144–7

    Article  PubMed  CAS  Google Scholar 

  41. Guigoz Y, Lauque S, Vellas BJ. Identifying the elderly at risk for malnutrition: the Mini Nutritional Assessment. Clin Geriatr Med 2002; 18: 737–57

    Article  PubMed  Google Scholar 

  42. Hanlon JT, Schmader KE, Ruby CM, et al. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001; 49: 200–9

    Article  PubMed  CAS  Google Scholar 

  43. Jyrkka J, Vartiainen L, Hartikainen SA, et al. Increasing use of medicines in elderly persons: a five year follow-up of the Kuopio 75+ study. Eur J Clin Pharmacol 2006; 62: 151–8

    Article  PubMed  Google Scholar 

  44. Alanen H-M, Finne-Soveri H, Fialova D, et al. Use of antipsychotic medications in older home-care patients: report from nine European countries. Aging Clin Exp Res 2008; 20: 260–5

    PubMed  Google Scholar 

  45. Noro A, Finne-Soveri H, Björkgren M, et al. Quality and productivity in institutional care for elderly residents: benchmarking with the RAI. Helsinki: National Research and Development Centre for Welfare and Health (STAKES), 2005

    Google Scholar 

  46. Hartikainen S, Klaukka T. Use of psychotropics is high among very old people. Eur J Clin Pharmacol 2004; 59: 849–50

    Article  PubMed  Google Scholar 

  47. Hartikainen S, Rahkonen T, Kautianen H, et al. Kuopio 75+ study: does advanced age predict more common use of psychotropics among the elderly? Int Clin Psychopharmacol 2003; 18: 163–7

    PubMed  Google Scholar 

  48. Linjakumpu TA, Hartikainen SA, Klaukka TJ, et al. Psychotropics among the home dwelling elderly: increasing trends. Int J Geriatr Psychiatry 2002; 17: 874–83

    Article  PubMed  CAS  Google Scholar 

  49. Martikainen P, Moustgaard H, Murphy M, et al. Gender, living arrangements, and social circumstances as determinants of entry into and exit from long-term institutional care at older ages: a 6-year follow-up study of older Finns. Gerontologist 2009; 49: 34–45

    Article  PubMed  Google Scholar 

  50. Ray WA, Meredith S, Thapa PB, et al. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 2001; 58: 1161–7

    Article  PubMed  CAS  Google Scholar 

  51. Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol 2007; 21: 217–30

    Article  PubMed  CAS  Google Scholar 

  52. Strandberg TE, Pitkälä KH. Frailty in elderly people. Lancet 2007; 369: 1328–9

    Article  PubMed  Google Scholar 

  53. Johnell K, Fastbom J. Concomitant use of gastroprotective drugs among elderly NSAID/COX-2 selective inhibitor users: a nationwide register-based study. Clin Drug Investig 2008; 28: 687–95

    Article  PubMed  CAS  Google Scholar 

  54. Raivio MM, Laurila JV, Strandberg TE, et al. Use of inappropriate medications and their prognostic significance among in-hospital and nursing home patients with and without dementia in Finland. Drugs Aging 2006; 23: 333–43

    Article  PubMed  Google Scholar 

  55. Iyer S, Naganathan V, McLachlan AJ, et al. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging 2008; 25: 1021–31

    Article  PubMed  Google Scholar 

  56. Ballard C, Hanney ML, Theodoulou M, et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009; 8: 151–7

    Article  PubMed  CAS  Google Scholar 

  57. Nishtala PS, McLachlan AJ, Bell JS, et al. Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry 2008; 16: 621–32

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this study. The authors have no conflicts of interest that are directly relevant to the content of this study. The data analysed and reported in this manuscript were collected as part of a larger study of nutritional care conducted by the City of Helsinki. The authors thank all staff of the long-term care wards in Helsinki for their enthusiastic support and participation.

Author information

Authors and Affiliations

  1. Division of Social Pharmacy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland

    Heidi T. Taipale &  J. Simon Bell

  2. Kuopio Research Centre of Geriatric Care, University of Kuopio, Box 1627, Kuopio, 70211, Finland

    J. Simon Bell

  3. Department of Pharmacology and Toxicology, University of Kuopio, Kuopio, Finland

    J. Simon Bell

  4. City of Helsinki Health Centre, Social Services, Helsinki, Finland

    Helena Soini

  5. Unit of General Practice, Helsinki University Hospital, Helsinki, Finland

    Kaisu H. Pitkälä

  6. Department of General Practice and Primary Health Care, Faculty of Medicine, University of Helsinki, Helsinki, Finland

    Kaisu H. Pitkälä

Authors
  1. Heidi T. Taipale
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Simon Bell
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Helena Soini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kaisu H. Pitkälä
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Simon Bell.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taipale, H.T., Bell, J.S., Soini, H. et al. Sedative Load and Mortality among Residents of Long-Term Care Facilities. Drugs Aging 26, 871–881 (2009). https://doi.org/10.2165/11317080-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11317080-000000000-00000

Keywords

Search

Navigation